DOLBY LABORATORIES, INC.
Ownership & governance
Executives 5Directors 8Avg age 59Avg tenure 10.7y
KY
Kevin Yeaman
Chief Executive Officer
Age 60Since 2009-03-30Profile →
+12
Executives5
Board of directors8
KY
Kevin Yeaman→
Director/Board Member
Age 60Since 2010-10-05
AT
Avadis Tevanian→
Director/Board Member
Age 65Since 2009-02-23
PG
Peter Gotcher→
Chairman
Age 67Since 2011-01-02
SS
Simon Segars→
Director/Board Member
Age 58Since 2015-02-02
AS
Anjali Sud→
Director/Board Member
Age 43Since 2019-05-12
ER
Emily Rollins→
Director/Board Member
Age 56Since 2021-02-23
TP
Tony Prophet→
Director/Board Member
Age 67Since 2021-12-05
DD
David Dolby→
Director/Board Member
Age 49Since 2010-12-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 10.28 % | 6,206,394 |
| Eaton Vance Management | 8.521 % | 5,142,166 |
| Vanguard Portfolio Management LLC | 8.237 % | 4,970,824 |
| BNY Mellon Investment Adviser, Inc. | 7.457 % | 4,499,820 |
| Vanguard Capital Management LLC | 4.518 % | 2,726,375 |
Catalog · 2026-07-09
SEC officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Edwin Marin | Chief Tech/Sci/R&D Officer | — | - |
| Marc Whitten | President and Chief Executive Officer | — | - |
| Peter Gotcher | Chairman | 2011-01-02 | - |
| Robert Park | Director of Finance/CFO | 2021-10-14 | - |
| Anjali Sud | Director/Board Member | 2019-05-12 | - |
| Avadis Tevanian | Director/Board Member | 2009-02-23 | - |
| David Dolby | Director/Board Member | 2010-12-31 | - |
| Emily Rollins | Director/Board Member | 2021-02-23 | - |
SEC · as of 2026-08-27
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 79Range 62–90Analysts 3
62Mean 7990
- Strong buy 1
- Buy 2
- Hold 1
Broker actions40 of 87
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Rosenblatt | Maintained | Buy | 85 | 2026-08-28 |
| Rosenblatt | Maintained | Buy | 85 | 2026-07-31 |
| Barrington Research | Maintained | Outperform | 90 | 2026-06-15 |
| Rosenblatt | Maintained | Buy | 85 | 2026-06-11 |
| Barrington Research | Maintained | Outperform | 90 | 2026-04-27 |
| Barrington Research | Maintained | Outperform | 90 | 2026-01-30 |
| Rosenblatt | Maintained | Buy | 85 | 2026-01-30 |
| Barrington Research | Maintained | Outperform | 90 | 2026-01-26 |
| Rosenblatt | Maintained | Buy | 85 | 2026-01-22 |
| Rosenblatt | Maintained | Buy | 85 | 2025-11-19 |
| Barrington Research | Maintained | Outperform | 95 | 2025-11-19 |
| Barrington Research | Maintained | Outperform | 100 | 2025-09-12 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.